Elbecta-S 1.5 Injection
Marketer
Elcliff Formulations Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Elbecta-S 1.5 Injection
Combiflox 1.5 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be solely under a physician's guidance. Consistent adherence to the prescribed schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Prior to use, inform your doctor of all current medications and pre-existing conditions. Pregnant or lactating individuals require physician consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occur. Ample rest, nutritious food, and hydration promote optimal recovery. Monitoring may involve supplementary lab tests to assess the drug's impact.
Primary Ingredients of Elbecta-S 1.5 Injection
No text provided to rephrase.
Uses of Elbecta-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Elbecta-S 1.5 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Elbecta-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Elbecta-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Elbecta-S 1.5 Injection works:
Elbecta-S 1.5 Injection unites Ceftriaxone, a bacterial growth inhibitor, and Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to survive. Sulbactam counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Elbecta-S 1.5 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Injections of Elbecta-S 1.5 are typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; however, corresponding research in humans is scarce.
Breast feedingCAUTION
Administration of Elbecta-S 1.5 Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Elbecta-S 1.5 Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Elbecta-S 1.5 Injection administration to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Elbecta-S 1.5 Injection to individuals with severe hepatic impairment requires careful consideration and potential dose modification. Patients with mild to moderate liver disease do not typically necessitate altered Elbecta-S 1.5 Injection dosages. Physician consultation is advised.
What if you forget to take Elbecta-S 1.5 Injection :
Should you forget a scheduled dose of Elbecta-S 1.5 Injection, seek your physician's advice.
Facts to Know About Elbecta-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently